CARLSBAD, Calif., Jan. 8, 2025
/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today
announced that Brett P. Monia,
Ph.D., chief executive officer, will present a company overview at
the 43rd Annual J.P. Morgan Healthcare Conference at
10:30 a.m. PT on Wednesday, January 15,
2025.
A live webcast of the presentation can be accessed on the
Investors & Media section of the Ionis website at
https://ir.ionis.com/events. A replay will be available on the
Ionis website within 48 hours and will be archived for a limited
time.
About Ionis Pharmaceuticals, Inc.
For three decades, Ionis has invented medicines that bring better
futures to people with serious diseases. Ionis currently has five
marketed medicines and a leading pipeline in neurology, cardiology,
and other areas of high patient need. As the pioneer in
RNA-targeted medicines, Ionis continues to drive innovation in RNA
therapies in addition to advancing new approaches in gene editing.
A deep understanding of disease biology and industry-leading
technology propels our work, coupled with a passion and urgency to
deliver life-changing advances for patients.
To learn more about Ionis, visit Ionis.com and follow us on X
(Twitter) and LinkedIn.
Ionis Investor Contact: D. Wade
Walke, Ph.D., ir@ionis.com – 760-603-2331
Ionis Media Contact: Hayley Soffer,
media@ionis.com – 760-603-4679
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-43rd-annual-jp-morgan-healthcare-conference-302346348.html
SOURCE Ionis Pharmaceuticals, Inc.